The MRCT Center released a series of case studies describing research stakeholder experiences of returning individual results to participants at a recent webinar.
Given the interest and number of questions we received, we offer three virtual “Digging Deeper” sessions to foster additional discussion and learning related to returning individual results.
The series will feature conversations with Pfizer, Yale University, and the National Cancer Institute representatives. Please register for one, two, or all by clicking the links below.
The third of the three sessions in this series will feature a moderated conversation with Megan Frone at the National Cancer Institute about considerations when returning genetic/genomic results.
Session 1: Pfizer’s Participant Data Return Solution
Thursday, July 27, noon EST – Paula Boyles, Pfizer
Session 2: IRB and HRPP Responsibilities
Thursday, August 17, noon EST – Linda Coleman and Madelon Baranoski, Yale University
Thursday, September 21, noon EST – Megan Frone, National Cancer Institute (NCI)